You are here: Industry Insights > Parkinson's disease

News List

Eisai discovers new compound to treat Parkinson's disease biospectrumasia
October 22, 2018
Researchers has identified a compound that has the potential to be a treatment for Parkinson's disease by using dopaminergic neurons differentiated from induced pluripotent stem (iPS) cells from patients with familial Parkinson's disease.
ProMIS Neurosciences Identifies Novel Antibody Drug Candidates for Parkinson's Disease americanpharmaceuticalreview
October 12, 2018
ProMIS Neurosciences announced the identification of several potential antibody therapeutic candidates aimed at selectively targeting toxic oligomers of the protein α-synuclein, considered a root cause of Parkinson's disease (PD).
FDA sets back review date of Acorda’s levodopa inhaler for Parkinson’s disease fiercebiotech
September 18, 2018
The agency set a new review deadline for Acorda’s levodopa inhaler, for Jan. 5, 2019, after requesting more info on its chemistry, manufacturing and controls.
FDA extends review of filing for Acorda's Inbrija in Parkinson's disease firstwordpharma
September 14, 2018
Acorda Therapeutics reported Thursday that the FDA extended its review of a filing seeking clearance of Inbrija (levodopa) by three months to January 5, 2019.
Calcium may play a role in the development of Parkinson's disease worldpharmanews
March 01, 2018
Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson's disease.
Asthma medicine reduses risk of Parkinson's by half worldpharmanews
September 04, 2017
Parkinson's disease is a chronic disease with unknown causes. The disease destroys the brain cells that control body movements. Shivering, stiff arms and legs and poor coordination are typical symptoms of Parkinson's.
Adamas scores orphan approval for tweaked generic Parkinson's med fiercepharma
August 28, 2017
Adamas' Gocovri is an extended-release formulation of generic amantadine.
For Parkinson's Patients, Singing May Be Good Therapy drugs.com
August 14, 2017
Singing may help to benefit people with Parkinson's disease, a researcher says.
Takeda and Prana to research neurodegeneration treatment for Parkinson's disease pharmaceutical-technology
July 20, 2017
Takeda Pharmaceuticals International has entered a new research collaboration to study the ability of Prana Biotechnology’s investigational movement disorders compound...
Britannia Pharmaceuticals: Landmark Apomorphine Study Confirms its Established Role as a Highly Effe en-cphi.cn
April 26, 2017
Results from the first randomized, controlled trial investigating the efficacy and safety of APO-go®/MOVAPO® (apomorphine) subcutaneous infusion in Parkinson's disease (PD) patients whose motor symptoms are not controlled by other therapies...

Previous page 1 2 3 Next page